Page 1 of 1

Novartis lung cancer drug gets priority U.S. review

PostMessage posted...: Wed Feb 12, 2020 7:02 am
by smix
Novartis lung cancer drug gets priority U.S. review
Reuters

URL: https://www.reuters.com/article/us-nova ... SKBN2050J9
Category: healthNews
Published: Tue, 11 Feb 2020 01:28:19 -0500

Description: Novartis has won fast-track U.S. regulatory review for capmatinib (INC280) in a hard-to-treat form of lung cancer, the Swiss drugmaker said on Tuesday.